The compound showed similar tumor-suppressive effects on these two cell lines (Fig. 5i and Supplementary Fig. 12i–k), as shown by its effects on cell viability, suggesting that DXI could inhibit cell growth regardless of KRAS mutation. Here, KRAS is linked to neoplasm.